Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study

Although infliximab is approved for psoriasis, its efficacy is reduced over time in some patients. The aim of this phase III trial is to evaluate efficacy and safety of infliximab dose escalation in Japanese psoriasis patients with loss of efficacy to standard‐dose therapy. Patients with plaque psor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Dermatol
Hlavní autoři: Torii, Hideshi, Nakano, Masayuki, Yano, Toshiro, Kondo, Kazuoki, Nakagawa, Hidemi, Fujita, Yasuyuki, Horie, Keita, Ito, Miki, Iitani, Mari, Ito, Kei, Kaneko, Takahide, Akasaka, Toshihide, Ohtuki, Mamitaro, Yasuda, Masato, Abe, Masatoshi, Tanida, Yurika, Terui, Tadashi, Arai, Satoru, Nakano, Toshiaki, Etoh, Takafumi, Asano, Yoshihide, Umezawa, Yoshinori, Saeki, Hidehisa, Adachi, Makoto, Seishima, Mariko, Tokura, Yoshiki, Morita, Akimichi, Yamanaka, Keiichi, Tani, Mamoru, Tanimura, Hirotsugu, Yamazaki, Fumikazu, Nishigori, Chikako, Kaneko, Sakae, Muto, Masahiko, Nakamura, Motonobu, Hino, Ryosuke, Nakayama, Juichiro, Nakano, Teruaki, Utani, Atsushi, Sato, Toshihiro, Ihn, Hironobu
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434916/
https://ncbi.nlm.nih.gov/pubmed/27882586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1346-8138.13698
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky